Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2012112363 - CATHEPSIN CYSTEINE PROTEASE INHIBITORS

Publication Number WO/2012/112363
Publication Date 23.08.2012
International Application No. PCT/US2012/024391
International Filing Date 09.02.2012
IPC
A61K 31/165 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
165having aromatic rings, e.g. colchicine, atenolol, progabide
CPC
A61K 31/277
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
275Nitriles; Isonitriles
277having a ring, e.g. verapamil
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 19/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
A61P 19/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
08for bone diseases, e.g. rachitism, Paget's disease
10for osteoporosis
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
C07B 59/001
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
59Introduction of isotopes of elements into organic compounds ; ; Labelled organic compounds per se
001Acyclic or carbocyclic compounds
Applicants
  • MERCK SHARP & DOHME CORP. [US]/[US] (AllExceptUS)
  • KASSAHUN, Kelem [US]/[US] (NZ, US)
  • FANDOZZI, Christine [US]/[US] (NZ, US)
  • GAUTHIER, Donald, R., Jr. [US]/[US] (NZ, US)
  • SHIPLEY, Lisa, A. [US]/[US] (NZ, US)
Inventors
  • KASSAHUN, Kelem
  • FANDOZZI, Christine
  • GAUTHIER, Donald, R., Jr.
  • SHIPLEY, Lisa, A.
Common Representative
  • MERCK SHARP & DOHME CORP.
Priority Data
61/442,36814.02.2011US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) CATHEPSIN CYSTEINE PROTEASE INHIBITORS
(FR) INHIBITEURS DE CYSTÉINE PROTÉASES, LES CATHEPSINES
Abstract
(EN) This invention relates to deuterated compounds which are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
(FR) La présente invention concerne des composés deutérés qui sont utiles pour le traitement de maladies dans lesquelles une inhibition de la résorption osseuse est indiquée, comme l'ostéoporose.
Related patent documents
Latest bibliographic data on file with the International Bureau